Healthcare

Articles

What would legalization and widespread availability of psilocybin therapy look like? Here, we connect with Dr. Sunil Aggarwal, a palliative care physician and cofounder of the Advanced Integrative Medical Science Institute (AIMS) in Seattle, Washington, to find out.

The Path to Legalized, Accessible Psilocybin Therapy

In this interview, learn about Nicole DiMonda’s incredible story and Jaime Brambila’s research efforts to document her case and help the lives of other cancer patients.

Medical Cannabis as an Adjunct Therapy to  Cancer Treatment: One Patient’s Journey from Diagnosis to Remission

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.

How Pharmaceutical Innovation Is Saving the World

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


A review on a handful of recent articles related to COVID-19 and cannabis as well as an interview with a top medical cannabis expert—Dr. Prakash Nagarkatti.

A Storm of Research Activity into Cannabis and Coronavirus A Closer Look at Expanding Research of Cannabinoids and Terpenes in COVID-19

An interview with Dr. Bonni Goldstein on treating patients during a pandemic, telemedicine, cannabis research, and more.

Treating Immunocompromised Patients During the COVID-19 Pandemic:  A Conversation with Dr. Bonni Goldstein

An interview with an amazing family of four doctors—the Knox Docs—who are key opinion leaders in cannabis therapeutics, endocannabinology, and cannabinoid medicine.

The First Family of Cannabinoid Medicine: The Knox Docs

A closer look at some of the current in vitro evidence suggesting that cannabinoids possess potent activity against a range of gram-positive bacteria.

The Role of Cannabinoids in the Global Fight Against Antibiotic Resistance 

Kentucky Passes Medical Cannabis Legislation

GW Pharmaceuticals recently announced the company’s financial results from the second quarter of 2019.

GW Pharmaceuticals Report for the Second Quarter of 2019

Here we review the current and pertinent literature in utilizing cannabis derivatives in animals and discuss the future forecast of cannabis in veterinary medicine.